Trial Details
TERMINATEDBasic Information
| Clinical ID | c3689 |
|---|---|
| Identifier | NCT01671956 |
| Trial Title | Evaluation of Safety, Efficacy, Pharmacokinetic and Pharmacodynamic of Bertilimumab in Patients With Active Moderate to Severe Ulcerative Colitis |
| Trial URL | Visit Original Page |
Study Information
| Study Results | YES |
|---|---|
| Conditions | Ulcerative Colitis, Active Moderate|Ulcerative Colitis, Active Severe |
| Interventions | BIOLOGICAL: Bertilimumab|BIOLOGICAL: Placebo |
Participant Information
| Sponsor | Alexion Pharmaceuticals, Inc. |
|---|---|
| City | Afula |
| Country/Region | Israel |
Enrollment Criteria
| Sex Requirement | ALL |
|---|---|
| Age Requirement | ADULT, OLDER_ADULT |
Study Design
| Study Type | INTERVENTIONAL |
|---|---|
| Phase | PHASE2 |
Time Information
| Start Date | 2015-07-31 |
|---|---|
| Primary Completion Date | 2018-08-31 |
| Completion Date | 2018-11-14 |